Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CS MEDICA Announces Positive Results from Clinical Trial of Nasal Protect Gel for Hay Fever/Allergic Rhinitis.

CS MEDICA's Nasal Protect Gel is a new and innovative treatment option that has demonstrated effectiveness in treating hay fever and allergic rhinitis, according to the results of a recent single-arm clinical trial.Copenhagen, Denmark - CS MEDICA, a medical device company specializing in innovative nasal products, today announced the results of a single-arm clinical trial evaluating the efficacy of Nasal Protect Gel in treating hay fever/allergic rhinitis. The study enrolled 60 subjects with a history of hay fever/allergic rhinitis during the high season of pollen for a period of two weeks.

Change in Optomed’s holding of treasury

Optomed Plc Stock Exchange Release 8 May 2023 at 13.00, Helsinki Change in Optomed’s holding of treasury A total of 3,500 of shares have been subscribed for under the Company’s stock option plans 2020A Optomed has used treasury shares for the share subscriptions. The subscribed shares have been delivered to the subscribers on 8 May 2023. The total amount of treasury shares is now 370 066. Optomed Plc Further enquiries Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com   Optomed in Brief  Optomed is a Finnish medical technology company and one of the

SmartCraft ASA (SMCRT) - Reminder: Invitation to presentation of first quarter 2023 results

SmartCraft ASA | Non-regulatory press releases 8 May 2023 - SmartCraft ASA will publish its first quarter 2023 financial report on Tuesday 9 May 2023 at 07:00 CET together with the Q1 2023 presentation material on the company website and www.newsweb.no. Investors, analysts, and journalists are welcome to join to an English language webcast presentation of the report on the same day, Tuesday 9 May 2023, at 08:00 CET. Webcast link: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20230509_1 Presenters: · Chief Executive Officer Gustav Line · Chief Financial

NOMOS wins iF Award for slender elegance

Slender and elegant, even with its automatic caliber—and now award-winning: Tangente neomatik 39 platinum gray. The sleek and beautiful stainless steel case of the Glashütte watch takes the shape of a coin.GLASHÜTTE, MAY 2023. It is one of the biggest award events and the oldest design prize in Germany: the prestigious iF Design Award has been presented once a year since 1954 by the world’s oldest independent design institution, iF International Forum Design GmbH. This year, the jury crowned Tangente neomatik platinum gray by NOMOS Glashütte: an elegant automatic watch full of technical

Resolutions at Sleep Cycle’s Annual General Meeting 2023

Gothenburg, Sweden, 8 May 2023 - At the Annual General Meeting (the “AGM”) of Sleep Cycle AB (publ) on 8 May 2023, the following was resolved.Adoption of the income statement and the balance sheetThe AGM adopted the income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet for the financial year 2022. Allocation of profitThe AGM resolved, in accordance with the Board of Directors’ proposal, on dividend of SEK 7.00 per share, of which SEK 1.00 per share is ordinary dividend for 2022 and SEK 6.00 per share is extraordinary dividend.

Enersense International Plc's Business Review January–March 2023: Revenue increased by 39% – full-year revenue expected to be over 300 MEUR

Enersense International PlcBusiness Review Q1 2023, 8 May 2023 at 12:05 p.m.The figures in brackets refer to the comparison period (the corresponding period of the previous year), unless otherwise stated. All figures and amounts have been rounded off from exact figures, which may result in minor inaccuracies in additions or subtractions. JANUARY–MARCH 2023 · Revenue was EUR 75.0 (53.8) million, 39.4% year-on-year. · EBITDA was EUR 0.1 (5.4) million. The EBITDA margin was 0.1 (10.1)%. · Adjusted EBITDA was EUR 0.4 (5.5) million, or 0.5 (10.2)% of revenue. · The operating

Södra celebrates anniversary of a world first for Liquid Forest certification

Our tall oil, turpentine and biomethanol were the first in the world at commercial scale to be certified to both FSC® (FSC-C006947) and PEFC (PEFC/05-35-48), offering peace of mind as an environmentally-conscious choice.“It’s almost a year now since we gained certification. It’s a great way for customers to understand that these are products from sustainably-managed forests,” says Viktor Odenbrink, Sales Director, Södra Bioproducts. “Interest in finding alternatives to fossil-based materials is escalating, but forests continue to be an emotive subject, so anything we can do to show

Metsä Board Corporation: Managers’ transactions (Metsäliitto Cooperative)

Metsä Board Corporation Stock exchange release Managers’ transactions 8 May 2023 at 12 noon EESTMetsäliitto Cooperative, which is a closely associated party to Metsä Board’s Chair and two members of the Board of Directors, has acquired on 4 May 2023 ja 5 May 2023 Metsä Board Corporation’s B shares. Metsä Board Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Metsäliitto Osuuskunta Position: Closely associated person (X) Legal person  (1):Person Discharging Managerial Responsibilities In Issuer

Carbiotix AB publishes a prospectus due to the upcoming rights issue

Carbiotix AB ("Carbiotix" or the "Company") announced on 27 April 2023 that the board, with the support of authorization from the annual general meeting, decided on a rights issue of units with preferential rights for the Company's shareholders. The Financial Supervisory Authority has today, on 8 May 2023, approved and registered the prospectus that Carbiotix prepared in connection with the rights issue. The prospectus is available on Carbiotix's website (www.carbiotix.com), Sedermera Corporate Finance AB's website (www.sedermera.se) and the Financial Supervisory Authority's website (www.fi.

Navamedic ASA: Invitation to 2023 1st quarter presentation

Oslo, May 8, 2023 - Navamedic ASA (OSE: Nava) will be presenting its first quarter 2023 results on Thursday May 11, 2023. The presentation will be held at Dronning Eufemias Gate 16 in Oslo and the event will start at 08.30 CET. A link to the webcast and the presentation will be available through the Navamedic web site on the following link: https://navamedic.com/investors/financial-results/   For further information, please contact: Kathrine Gamborg Andreassen, CEO, +47 951 78 680 E-mail: kathrine@navamedic.com Lars Hjarrand,CFO, +47 917 62 842 E-mail: lars.hjarrand@navamedic.

Brain+ Online Investor Update

Copenhagen, Denmark, May 8, 2023 – Brain+ A/S (Nasdaq First North: BRAINP)On Monday 15 May 2023 at 16:00 CEST, Brain+ will host an online Investor Update. The Investor Update will start with a presentation from the CEO, Kim Baden-Kristensen followed by a Q&A session where the CEO will answer questions from investors.  The Q&A is already open, meaning that you can already now submit your questions and vote for the best questions submitted by other investors. Brain+ has made this new solution available to make sure all interested can participate with their questions even though they may

New patent about to be approved for Nexam Chemical

Nasdaq First North-listed Nexam Chemical – which invents, develops, produces and sells additives to the plastics industry worldwide – has received confirmation that a new patent will be approved. The patent naturally falls under Nexam's single largest application area, PET foam, and concerns an additive combination that can improve the processing properties of polyester materials. It is the first new patent obtained in several years.With the help of this new additive combination, it is possible to further improve the production of high-value core materials for, for example, wind turbine

Stena Line at Transport Logistic 2023 – demonstrating a sustainable European logistics network

New intermodal connections, the latest updates on route network and fleet, and a clear sustainability strategy – the Stena Line team is looking forward to meeting new and existing partners and customers to discuss tomorrow’s logistics solutions at the Transport Logistic event in Munich 9-12 May!Stena Line is on an exciting journey, growing its European route network, investing in new vessels, long term port relationships and sustainable technologies. All this combined with a high customer focus and close cooperation with rail operators makes Stena Line a strong partner for RoRo freight but

Normet considers issuance of new capital securities and announces voluntary tender offer for its outstanding capital securities issued in 2020

Normet Group Ltd.           Press release   8 May 2023 at 11:00 EEST NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL Normet considers issuance of new capital securities and announces voluntary tender offer for its outstanding capital securities issued in 2020 Normet Group Ltd. (“Normet” or the “Company” and together with its subsidiaries “

Resolutions at the annual general meeting in Bokusgruppen AB (publ)

At the annual general meeting in Bokusgruppen AB (publ) today on 8 May 2023, income statements and balance sheets for 2022 were adopted and it was resolved on, among other things, dividends of a total of SEK 3.00 per share, re-elections of all board members and election of Patrik Wahlén as new board member. Furthermore, the general meeting resolved on re-election of Ernst & Young Aktiebolag as the auditor.Adoption of income statements and balance sheets The annual general meeting adopted the income statement and the balance sheet as well as the consolidated income statement and the

INVISIO unveils new ultimate warfighter hub and PTT

INVISIO today announces its latest development in mission critical communications - the INVISIO V60 Gen II ADP - an advanced PTT and warfighter hub that bridges audio, data, and power. It provides more functionality and flexibility whilst integrating systems and data to reduce the number of devices carried by dismounted soldiers. The V60 II ADP builds on previous iterations of INVISIO’s V-Series, adding the capability to enable audio cues from EUD (End User Device) to headset, as well as distributing power to EUDs or other devices. This reduces cables, devices, and complexity. The new

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them

Company Announcement No. 53 -2023 OrderYOYO A/SManagers’ transactions   Copenhagen, May 8, 2023   OrderYOYO A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 (the market abuse regulation) of the below transactions related to shares in OrderYOYO A/S made by TJOYY22 ApS, closely associated to CEO Jesper Johansen, who has acquired 2,716 shares in OrderYOYO A/S at an average price of DKK 4.944 per share.  1. Details of the person discharging managerial responsibilities/person closely associateda) Name

WiSig Networks, Sivers Semiconductors and Intel demonstrate 5G millimeter-wave backhaul technology at G20 Event

Representatives from G20 nations attending the G20 digital economy event in Hyderabad, India, expressed strong interest in the product, which combines Sivers millimeter-wave chip and antenna module solutions with WiSig Networks’ modem and software stack implemented on the Intel Agilex FPGA.Representatives from G20 nations attending the Second Meeting of the G20 Digital Economy Working Group (DEWG) in Hyderabad visited IIT-Hyderabad, and experienced a demonstration of the WiSig-Sivers-Intel 5G standalone millimeter-wave integrated backhaul product, which was first demonstrated earlier this

TYRI increases INTELLilight® forecast by 100% for 2023 – production will be required in all factories to meet demand.

TYRI, the world leader in work lighting for heavy machinery, had high expectations for 2023 and the launch of INTELLilight® on the international market. However, it is only April, and the company has had to increase its sales forecast by 100% for the full year. Production that has been conducted so far in the Swedish factory will be scaled up and the UK and USA factories will start producing INTELLilight® as soon as possible.Martin Karlberg, CEO and one of the founders of TYRI says, "INTELLilight® has been incredibly well received on the international market. Several of the major machine

Cline Scientific's CEO is taking a break from the position of CEO at his own request

Cline Scientific AB (publ) ("Cline" or the "Company") CEO Patrik Sundh has, at his own request, informed the Company's board that he has decided to take a break from the position of CEO until the investigation into suspected market manipulation is complete. The Board of the Company has appointed Hanne Evenbratt as Acting CEO during this time.In order not to influence the Company, CEO Patrik Sundh has stated to the board that as of today, May 8, he intends to take a break from his position as CEO until it is clear what the preliminary investigation shows. The board has granted this request

Cline Scientific decides to postpone rights issue

Cline Scientific AB (publ) ("Cline" or the "Company") has, following Friday's news regarding the company's CEO, decided to postpone the rights issue whose subscription period was to begin today, May 8.Due to the uncertainties surrounding the company's CEO, who has been notified of suspicion of market manipulation, the Company's board, on the advice of advisors, has decided to postpone the announced rights issue. The company will return with further information when the issue will be carried out.   The company is listed on the Nasdaq First North Growth Market. Redeye AB is Cline

BioStock: Alligator Bioscience’s CEO on the rights issue

Alligator Bioscience is developing tumour-directed antibody-based treatments against cancer. At the beginning of the year, the company reported positive interim results from the OPTIMIZE-1 phase II study in pancreatic cancer with lead candidate mitazalimab. Since then, Alligator has not slowed down. The company is now carrying out a rights issue of approximately SEK 199 million. Alligator's CEO Søren Bregenholt visited the BioStock Studio to tell us more.Watch the interview with Søren Bregenholt at biostock.se: Alligator Bioscience’s CEO on the rights issue - BioStock 

There are no items matching the current filter
There are no more items matching the current filter
Back to top